White matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegeneration

INTRODUCTION: Cognitive tests and nonamyloid imaging biomarkers do not consistently identify preclinical AD. The objective of this study was to evaluate whether white matter hyperintensity (WMH) volume, a cerebrovascular disease marker, is more associated with preclinical AD than conventional AD bio...

Descripción completa

Detalles Bibliográficos
Autores principales: Kandel, Benjamin M., Avants, Brian B., Gee, James C., McMillan, Corey T., Erus, Guray, Doshi, Jimit, Davatzikos, Christos, Wolk, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Neuroimaging
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950175/
https://www.ncbi.nlm.nih.gov/pubmed/27489875
http://dx.doi.org/10.1016/j.dadm.2016.03.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950175/
https://www.ncbi.nlm.nih.gov/pubmed/27489875
http://dx.doi.org/10.1016/j.dadm.2016.03.001

Ejemplares similares